- Home
- RVYL vs PRTG Comparison
RVYL vs PRTG Comparison
Compare RVYL & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- PRTG
- Stock Information
- Founded
- RVYL 2007
- PRTG 1973
- Country
- RVYL United States
- PRTG British Virgin Islands
- Employees
- RVYL 99
- PRTG N/A
- Industry
- RVYL Professional Services
- PRTG Oil & Gas Production
- Sector
- RVYL Consumer Discretionary
- PRTG Energy
- Exchange
- RVYL Nasdaq
- PRTG Nasdaq
- Market Cap
- RVYL 8.3M
- PRTG 8.1M
- IPO Year
- RVYL N/A
- PRTG N/A
- Fundamental
- Price
- RVYL $0.99
- PRTG $4.57
- Analyst Decision
- RVYL Hold
- PRTG
- Analyst Count
- RVYL 1
- PRTG 0
- Target Price
- RVYL N/A
- PRTG N/A
- AVG Volume (30 Days)
- RVYL 92.3K
- PRTG 129.9K
- Earning Date
- RVYL 03-25-2025
- PRTG 03-03-2025
- Dividend Yield
- RVYL N/A
- PRTG N/A
- EPS Growth
- RVYL N/A
- PRTG N/A
- EPS
- RVYL N/A
- PRTG N/A
- Revenue
- RVYL $63,529,000.00
- PRTG N/A
- Revenue This Year
- RVYL N/A
- PRTG N/A
- Revenue Next Year
- RVYL $48.92
- PRTG N/A
- P/E Ratio
- RVYL N/A
- PRTG N/A
- Revenue Growth
- RVYL 16.09
- PRTG N/A
- 52 Week Low
- RVYL $0.89
- PRTG $2.10
- 52 Week High
- RVYL $4.65
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- RVYL 33.69
- PRTG 48.57
- Support Level
- RVYL $1.14
- PRTG $4.46
- Resistance Level
- RVYL $1.27
- PRTG $5.00
- Average True Range (ATR)
- RVYL 0.09
- PRTG 0.61
- MACD
- RVYL -0.02
- PRTG 0.00
- Stochastic Oscillator
- RVYL 8.11
- PRTG 50.00
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.